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Abstract We studied tuberculin reactivity in young Norwegian adults and its possible dependency on age, gender,
previous BCG vaccination, smoking habits, occupational exposure, diet as well as years of education as a measure of
socio-economic status.Responders of a random sample ofmen andwomen aged 20–44 years living in Bergen,Norway
wereinterviewedandtestedwiththe adrenaline-PirquettestwithNorwegian-producedsyntheticmediumtuberculin at
the out-patient chest clinic in the city of Bergen in1992–1993.Nine hundred and three subjects out of 1200 met for the
clinical examination (75%).Five hundred and eighty-eight subjectswere tuberculin-tested and read, whereof 95% were
BCGvaccinatedbyage14.Meantuberculinreactivitywas 4.8mm (SD: 3.0mm).Apositivereaction (4mm)was foundin
64%, whereof 7% had a strongly positive reaction (10mm). A negative reaction (o4mm) occurred in 36%, whereof
10% had no reaction (0mm).Only 30% of the females and 36% of the males aged 21--25 years were tuberculin positive
7–12 years after BCGvaccination.Linearregression analysis demonstrated tuberculinreactivity to increasewith increas-
ingage, male genderwith anincreasing sexeffect byage, and current smoking.Occupational dustorgas exposure, a diet
rich in vitamin C or years of education did not influence tuberculin reactivity significantly.r 2002 Elsevier Science Ltd.
Allrights reserved.
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Although introducedalmost a100 years ago (1) tuberculin
testing is still themost commonly used test for tubercu-
losis infection.However, the fraction of subjects reacting
to tuberculin in a population is in£uenced by the rate of
BCGvaccination (2) and non-tuberculous mycobacterial
infections.
The incidence of tuberculosis in Norway in1989^1993
was 6.4 per 100 000 inhabitants and for those born in
Norway 4.4 per 100.000 inhabitants, respectively (3).
Pulmonary tuberculosis accounted for approximately
70% of the cases. Immigrants from high incidence coun-
tries accounted for 40% of all incident cases of tubercu-
losis in Norway in the study period1992^1993.
Tuberculin testing, BCGvaccination of theNorwegian
population and screening with mass miniature chest X-
ray were introduced by law in1947.The BCGvaccinationReceived16 April 2002, accepted in revised form 29 April 2002.
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ly given to pupils at school at age14.
Non-tuberculous mycobacteria (NTM) are known to
induce positive tuberculin reactions.This has been docu-
mentedby Bjerkedal (4) inNorway (1961^1962) and Lars-
son (5) in Sweden (1986^1990), in large population
studies of not-BCG-vaccinated children, when testing
with tuberculin-like products produced fromNTM (sen-
sitins).They both concluded that NTM were responsible
for most of the tuberculin reactivity in not-BCG-vacci-
nated Scandinavian children.
Eilertsen (6) demonstrated 30 years ago in his tuber-
culin studies (Danish old tuberculin), of young adults in
Bergen, Norway, that BCG vaccination resulted in a po-
sitive tuberculin reaction in 94% of the subjects, stabiliz-
ing after 10^15 years at a positive tuberculin rate of
about 65%. A recent study of 2629 pupils in 1990^1994
byThe Norwegian Health Screening Service (7) showed
a positive adrenaline-Pirquet tuberculin test (4mm) 2
months after BCG vaccination in 84% of the pupils. Tu-
berculin reactivity has not been examined in Norway
since theWaaler report in1975 based on tuberculin data
up to 1968 (2). Our routine tuberculin testing of young
adults in the early 1990’s suggested that only one out of
1034 RESPIRATORYMEDICINEfour subjects having been BCG vaccinated 7^12 years
earlier reacted to tuberculin. This might indicate a sub-
stantial change in long-lasting tuberculin reactivity in
BCG-vaccinated subjects of unknown reasons.
The objective of the paper is to describe tuberculin
reactivity in a young Norwegian population with a high
coverage of BCG vaccination. Furthermore, we wanted
to evaluate possible predictors of tuberculin reactivity
such as age, sex, smoking habits, as well as other factors
related to lifestyle assessed as occupational dust expo-
sure, socio-economical status judgedbyeducational level
and dietary intake of vitamin C.
METHODSANDSUBJECTS
Study population
A random sample of 1200 men and women aged 20^44
years, living in the city of Bergen, Norway August 1st
1990, was drawn by the Central Population Registry.The
1200 subjects, being selected from a population of about
90 000,were invited to participate in theNorwegianpart
of the European Community Respiratory Health Survey
(ECRHS) (8).This selection of subjects was also included
in a tuberculin survey. The interviews and investigations
tookplace at theHordalandCountyChestUnit fromSep-
tember 1992 to June 1993. A questionnaire and an inter-
view revealed prior tuberculin status, BCG vaccination,
smoking habits, occupational dust or gas exposure, diet-
ary vitamin C intake and age when ¢nishing education as
a measure of socio-economic status.
The tuberculin test
The standard Norwegian test, a modi¢cation of von Pir-
quet’s skin scari¢cation method, with Norwegian-pro-
duced synthetic medium tuberculin (SMT) and
adrenaline, was applied (9). Two drops of the SMT and
adrenaline solution were placed on the volar side of the
left arm, 5 and10 cm below the cubital line, respectively.
A 5mm skin scratchwasmadewith a lancet through the
solution placed on the skin.The duplicate test reactions
were to be read within 48^72h and assessed as the
greatest measure of the in¢ltration perpendicular to
the scratch. The larger of the duplicate reactions was
used. An experienced public health nurse performed all
tuberculin testing and reading.We de¢ned a positive re-
action as an in¢ltrate 4mm. A strongly positive reac-
tion (10mm) may indicate tuberculosis transmission
despite previous BCGvaccination (7).
Wehavepreviously shown that the adrenaline-Pirquet
tuberculin test is as reproducible (10) as the Mantoux
PPD test (11), but less sensitive (12). The adrenaline-Pir-
quet tuberculin test gave 11^16% less positive reactors
than the Mantoux PPD 5 TU and 2 TU tests (12).BCGvaccination
BCG vaccination has been compulsory in Norway since
1947 with an adherence of 95% or more of the popula-
tion. Since1995 BCGvaccination hasbeen recommended
on a voluntary basis. As in earlier years all pupils in ele-
mentary school, usually at age 14, is BCG vaccinated by
the public school health nurse. In Norway, the Bergen
strain of BCGwas applied up to January1972 and there-
after the Copenhagen strain.
Smoking habits, occupational exposures,
socio-economic status anddiet
Smokerswere subjectswho reported to havebeen smo-
kers for asmuch as one year, smoking at least1cigarette
a day/1cigar a week or having smoked at least 400 cigar-
ettes/360g tobacco during their lifetime. The smokers
were further divided into light smokers consuming 1^9
cigarettes daily, moderate smokerswith10^19 cigarettes
daily andheavy smokers taking at least 20 cigarettes dai-
ly. Cigar or pipe tobacco smoking was registered as
grams of tobacco smokedper day with1cigarette equal-
ing 1g of tobacco. Ex-smokers were subjects who re-
ported to have been smokers according to the
de¢nition above and to have stopped smokingmore than
1 month prior to answering the questionnaire. Never
smokers were subjects who denied smoking according
to the applied de¢nition (8).
Occupational, airborne exposure to dust or gas was
assessed by asking: ‘‘Have you ever had a job that ex-
posed you to vapors, gas, dust or fumes?’’ The answers
were given as yes or no. Dietary vitamin C intake was
assessed by a semi-quantitative food-frequency ques-
tionnaire as the daily intake of orange or orange juice,
potatoes, carrots or tomatoes. The questionnaire was
originally developed by Channing Laboratory, Harvard
Medical School, and has documented acceptable repro-
ducibility and validity (13,14).
Socio-economic status was assessed as level of educa-
tion (15). Information about agewhen education was ¢n-
ished was obtained from the questionnaire. A low level
of education was de¢ned as ¢nishing education at age16
or younger, a medium level when ¢nishing education at
age17^19 years and a high level when ¢nishing education
at age 20 years or older.
Statisticalmethods
Non-attendants, attendants who did not complete the
tuberculin test program and attendants tested and read
were comparedwith respect to age and sex distribution
by one-way analysis of variance and chi-square tests,
respectively (16,17). Age was calculated from year
of birth to test year (1992 or 1993). The mean adrena-
line-Pirquet tuberculin reactivity was compared bet-
TUBERCULINREACTIVITY 1035ween BCG-vaccinated and not-BCG-vaccinated groups
and childhood tuberculin converters, using Student’s
t-test (17).
To study the relationship of the adrenaline-Pirquet re-
action with age, gender, smoking classi¢cation groups,
occupational exposure, educational level and dietary vi-
tamin C intake, we applied multiple linear regression
analyses (17).
RESULTS
Nine hundred and three persons (75%) attended the
study. The sex and age distribution for non-attendants
(n=297), attendants not included (n=315) and atten-
dants tuberculin tested and read (n=588) are presented
inTable1. Attendants not includedwere either not tuber-
culin tested due to eczema (n=12), tested but not read
(n=301) or they had only one adrenaline-Pirquet scratch
(n=2).The attendantshad a highermean age and a higher
percentage of women than the non-attendants and
those testedbut not included.
Outof the studypopulation of 588 subjects, 558 BCG-
vaccinated subjects had a mean adrenaline-Pirquet tu-
berculin reactivity of 4.8mm (SD: 3.0mm). The 20 sub-
jects who denied having had a BCG vaccination had a
mean tuberculin reaction of 3.6 mm (SD: 2.5mm)
(P=0.28).Ten persons with missing data regarding BCG
vaccination had a mean tuberculin reactivity of 5.0mm
(SD: 3.1mm).Nine childhood tuberculin converters had a
mean reactivity of 5.8mm (SD: 2.0mm) andwere not sig-
ni¢cantly di¡erent from the BCG-vaccinated group
(P=0.35). Nor did they di¡er from nine subjects who
neither knew their previous BCG status nor theirTABLE 1. Characteristics of a random sample fromayoung No
Non-
attendants
Attenda
tubercul
notread
n= 297 n= 315
Age (years)
mean 32.1 32.7
SD 6.6 6.3
Gender,
men: n (%) 176 (59.3) 164 (52.1
women: n, (%) 121 (40.7) 151 (47.9)
Childhood tuberculin
converters, n (%)b F F 8 (2.5)
BCGvaccinated
n (%) F F 310 (98.4
*p-values fromone-way analyses of variance (age) and chi-squ
aTwelve subjectswerenottested due to eczema and two subjec
bSubjects who were not-BCG-vaccinated because they teste
planned BCGvaccination at age14.tuberculin status (mean: 5.6mm; SD: 3.3mm). The BCG
vaccination status was, in addition to the questionnaire
data, documented from records in 278 subjects.
Figure 1 presents the distribution of tuberculin
reactivity for the 588 participants. A positive reaction
(4mm) was found in 64%, whereof 7% had a strongly
positive reaction (10mm). The 297 men had a
mean tuberculin reactivity of 4.8mm (SD: 3.1mm) with
68% being tuberculin positive, while 291 women had a
mean reactivity of 4.4mm (SD: 2.8mm) and 59.8%
positivity.
Figure 2 presentsmeanvalues and standard deviations
in millimeter of tuberculin reactivity for every year of
age for the participants. To ease comparison between
the read adrenaline-Pirquet reactions and Mantoux PPD
reactivity, we added aMantoux 2 TUPPD axis, based on
the linear regression equation we have previously pre-
sented (12).
Table 2 presents tuberculin reactivity in 5-year-age
groups separately for men and women.We observed a
signi¢cant increase in tuberculin reactivity by increasing
age (Po0.01) both for men and women.Therewas also a
signi¢cant sex di¡erence with larger reactions in men
than in women (Po0.01). For those 21^25 years of age,
being BCG-vaccinated 7^12 years earlier, the tuberculin
reaction in women was 2.6mm (SD: 2.4mm) and in men
2.9mm (SD: 2.7mm). In the same age group, the rate of a
positive tuberculin reaction (4mm)was 30% inwomen
and 36% in men. In the oldest age group from 41^46
years, the rate of a positive tuberculin reaction was 71%
inwomen and 89% inmen.
Table 3 presents the results of the stepwise multiple
linear regression analysis for predictors of tuberculin re-
activity in this young adult population. Increasing age,rwegianpopulationbyresponse status (n= 1200)
nts
intestedbut
a
Attendants
tuberculin tested
andread
p- value*
n= 588
o0.01
34.0
6.9
0.04
) 297 (50.5)
291 (49.5)
0.22
9 (1.5)
0.12
) 558 (94.9)
are test.
ts had an incomplete test.
d tuberculin positive in childhood or when screened before
FIG. 1. Distribution of adrenaline-Pirquettuberculin reactivityinyoung Norwegian adults (n= 588).
FIG. 2. Mean adrenaline-Pirquettuberculin reactivity inyoung Norwegian adults by age (n= 588).
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smoking predicted independently tuberculin reactivity
after adjusting for educational level, a marker of socio-
economic status.The sex and age interaction ismore ea-
sily shown inTable 2,where tuberculin reactivity is higher
in men than in women but di¡erentially by age.The gen-
der di¡erence was most pronounced in the oldest age
groups. No dose-response e¡ect of tobacco smoking
was found.No statistical signi¢cant e¡ectswere demon-strated for occupational dust or gas exposure and vita-
min C intakewhen added to themultivariatemodel.
DISCUSSION
We observed that 64% of the subjects in a young BCG-
vaccinatedNorwegianpopulationhad a positivereaction
(4mm) to the adrenaline-Pirquet tuberculin test. A
TABLE 2. Adrenaline-Pirquettuberculin positive results (4mm) in 588 Norwegian adults aged 21^46 yr
Sex Age n Percent
tuberculin
positive
Meantuberculin
reactivity
(mm)
Standard
deviation
(mm)
Male 21^25 44 36.4 2.9 2.7
Female 21^25 37 29.7 2.6 2.4
Male 26^30 64 59.4 4.3 3.0
female 26^30 76 56.6 4.3 2.9
Male 31^35 61 65.6 5.1 2.9
Female 31^35 57 57.9 57.9 4.5
Male 36^40 67 80.6 6.1 2.9
Female 36^40 65 72.3 4.9 2.6
Male 41^46 61 88.5 6.8 2.8
Female 41^46 56 71.4 5.1 2.8
Male 21^46 297 68.0* 5.2 3.1
Female 21^46 291 59.8* 4.4 2.8
Total 21^46 588 63.9 4.8 3.0
*Males vs. females using Pearson’s chi-square test:P= 0.0002.
TABLE 3. Multiple linear regression model for adrenaline-Pirquet tuberculin reactions (mm) in young Norwegian adults
(n= 558)
Regression
coe⁄cient
Standard
error
P value
Constant 1.802
Age (yr) 0.186 0.024 o0.001
Sex (male = 0, female = 1) 2.088 1.153 0.070
Sexage interaction 0.083 0.033 0.014
Smokinga 0.016
Ex-smokers 0.213 0.349
Light smokers (9 cigarettes/day) 1.083 0.372
Medium smokers (10^19 cigarettes/day) 0.723 0.310
Heavy smokers (20 cigarettes/day) 0.779 0.425
Educationallevel 0.125
17^19 yr 0.005 0.365
20 yr 0.490 0.314
*Agewhen ¢nishing education.
aRegression coe⁄cients are relative to the reference categories (zero) which are never smokers andr16 years, respectively.
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had no reaction (0mm). However, only 30% of the fe-
males and 36%of themales aged 21^25 yearswere tuber-
culin positive 7^12 years after BCG vaccination.
Tuberculin reactivity was signi¢cantly predicted by gen-
der, age and smoking habits.
Out of the random sample of 1200 men and women
our study comprised 588 subjects who were tuberculin
tested and read (49%). As in other population studies
performed in the same area (18), those who completed
the tuberculin study were older and included a greater
proportion of women.We didnotobserve signi¢cant dif-ferences in the frequency of attendancewhen comparing
those being spontaneous tuberculin converters with
thosehavingreceivedprevious BCGvaccination.We thus
believe that the small age and gender di¡erences ob-
served should not have biased our results substantially.
However, we do not have the readings of the tubercu-
lin reactions of 35% of those tested.One may speculate
whether subjects with a small or a negative tuberculin
reaction would be less likely to return for tuberculin
readings. In addition, younger subjects have lower tuber-
culinreactivity and a lower attendancerate in this survey.
Consequently, the proportion of tuberculin positive re-
1038 RESPIRATORYMEDICINEactorswouldbe even lower thanwhatwehave observed
in our youngest 21^25 year age group, resulting in an un-
derestimate of the tuberculin reactivity in the youngest
age groups.
The adrenaline-Pirquet test with Norwegian-pro-
duced synthetic tuberculin (9) has long historical stand-
ings and has been regularly quality assessed by the
NorwegianNational Health Screening Service (7). In co-
herence with clinical tradition (7) the tuberculin-setting
and readings were performed by the same well-trained
public health nurse.We have previously shown that the
adrenaline-Pirquet tuberculin test is as reproducible (10)
as the Mantoux PPD test (11), but less sensitive (12).
Tuberculin reactivity in this cross-sectional study in-
creased with increasing age. Cross-sectional investiga-
tions by the Norwegian National Health Screening
Service (7) observed in 1990^1994 a tuberculin positive
rate of 84% in children 2 months after BCGvaccination.
Larson et al. (19) found 49% positive tuberculin (PPD
RT23) reactors in 8^9-year-old Swedish children BCG
vaccinatedwithin their ¢rst 2 years of life.Miret-Cuadras
et al. (20), Spain, reported tuberculin (5TU PPD RT23)
reactivity in 13^25 year old subjects BCG vaccinated at
birth and 20^25-year-old subjects BCG vaccinated at
age 6^14. Positive reactions (5mm) were found in 64%
of the males and in 60% of the females.When using our
(12) transition equation for the relationship between the
adrenaline-Pirquet tuberculin test and theMantoux PPD
RT23 5 TU (12), we calculated that 52% of the subjects in
our study wouldhave reactedpositively in the age-group
20^25 years.This di¡erence between Spain and theNor-
dic countries is not a BCGe¡ect as the same BCG strain
has been applied. However, it may be related to the ten
timeshigher riskof tuberculosis infection in Spain than in
Norway (20).
Kr˛ger et al. (21) studied tuberculin (PPD RT23) reac-
tivity in 4^6-year-old Finnish children who were BCG
vaccinated at birth and again at age 10^12. They found
that the mean tuberculin reactivity decreased from
4.8mm to 3.4mm and concluded that contact with my-
cobacteria, either with Mycobacterium tuberculosis or
environmental mycobacteria, was too rare to maintain
tuberculin responsiveness. Eilertsen (6) studied the tu-
berculin reactivity in BCG Bergen strain vaccinated
young adults in the1960s and followed them for15 years.
The rate of positive tuberculin reactors dropped from
96% the ¢rst year to approximately 65% 15 years after
vaccination. The decline in tuberculin reactivity in our
study compared with Eilertsen’s data may partly be due
to a cohort e¡ect re£ecting a higher risk of tuberculosis
infections in the 1950^1960s. In addition, the cohort ef-
fectmight be explained by other factors including expo-
sure to environmental mycobacteria or tobacco
smoking.
The lower tuberculin reactivity inwomen than inmen
in the older age groups, independent of tobacco smok-ing, is di⁄cult to explain. Men may be more heavily ex-
posed to mycobacteria or there may be gender
di¡erences in immune reactivity (22). Our observations
are in accordancewith previous reports (23).
We found a strong and independent e¡ect on tubercu-
lin reactivityby tobacco smoking, butno dose^response
relationship.WhileGulsviketal. (24) foundlower levels of
IgA, IgG and IgM in smokers, Omenaas et al. found in
1994 (25) that smokers had a higher IgE level than non-
smokers. Anderson et al. (26) studied cigarette smoking
and tuberculin conversion among inmates in prisons.
They suggested that smokers were more likely to be-
come tuberculin skin test converters than non-smokers
re£ecting a reduced mucociliary clearance of potential
pathogens such as non-tuberculous mycobacteria or of
Mycobacterium tuberculosis.
This study shows that the prevalence of a positive tu-
berculin reaction in this young Norwegian population,
BCGvaccinated at age14, was 64%.Tuberculin reactivity
was predicted signi¢cantly by increasing age, with an in-
creasingmale e¡ect by aging and current smoking.
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